Scientists test new 'Long-Lasting' breast cancer drug shot in healthy volunteers
Knowledge-focused
Ongoing
This is an early-stage study to learn about the safety and how the body processes a new, long-acting injectable form of the drug letrozole. It involves about 90 healthy post-menopausal women who will receive a single injection at different dose levels. The main goal is to gather …
Phase: PHASE1 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:23 UTC